Single-cell profiling approaches to probing tumor heterogeneity

International Journal of Cancer

Volumn 139, Issue 2, 2016, Pages 243-255

  Khoo, Bee Luan ^a,b   Chaudhuri, Parthiv Kant ^a   Ramalingam, Naveen ^c   Tan, Daniel Shao Weng ^d,e   Lim, Chwee Teck ^a,b,f   Warkiani, Majid Ebrahimi ^b,g  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^c FLUIDIGM CORPORATION   (United States)

^d Singapore   (United States)

^e GENOME INSTITUTE OF SINGAPORE   (Singapore)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

cancer; heterogeneity; microfluidics; molecular analysis; single cell analysis; tumors

Indexed keywords

DNA; RNA;

CANCER CLASSIFICATION; CELL HETEROGENEITY; CELL STRUCTURE; CYTOLOGY; CYTOMETRY; DNA DETERMINATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HIGH THROUGHPUT SEQUENCING; HUMAN; INTERMETHOD COMPARISON; LIPID ANALYSIS; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROFLUIDIC ANALYSIS; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; RNA ANALYSIS; SINGLE CELL ANALYSIS; TIME OF FLIGHT MASS SPECTROMETRY; ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METABOLOMICS; NEOPLASM; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METABOLOMICS; NEOPLASMS; PROTEOMICS; SIGNAL TRANSDUCTION; SINGLE-CELL ANALYSIS;

EID: 84959132634     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30006     Document Type: Review

References (119)

1. Schor SL, Schor AM., Phenotypic and genetic alterations in mammary stroma: implications for tumour progression. Breast Cancer Res 2001; 3: 373-9.
2. Greaves M, Maley CC., Clonal evolution in cancer. Nature 2012; 481: 306-13.
3. Lawrence MS, Stojanov P, Polak P, et al., Mutational heterogeneity in cancer and the search for new cancer-Associated genes. Nature 2013; 499: 214-8.
4. Meacham CE, Morrison SJ., Tumour heterogeneity and cancer cell plasticity. Nature 2013; 501: 328-37.
5. Shapiro E, Biezuner T, Linnarsson S., Single-cell sequencing-based technologies will revolutionize whole-organism science. Nat Rev Genet 2013; 14: 618-30.
6. Spencer SL, Gaudet S, Albeck JG, et al., Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009; 459: 428-32.
7. McCarthy N., The cancer kaleidoscope. Nat Rev Cancer 2014; 14: 151-2.
8. Chapman PB, Hauschild A, Robert C, et al., Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507-16.
9. Kwak EL, Bang YJ, Camidge DR, et al., Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010; 363: 1693-703.
10. Singh AK, Arya RK, Maheshwari S, et al., Olivier Dormond4 andDipak Datta1,2. Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance. Int J Cancer 2014; 136 (9): 1991-2000.
11. Navin N, Kendall J, Troge J, et al., Tumour evolution inferred by single-cell sequencing. Nature 2011; 472: 90-6.
12. Min JW, Kim WJ, Han JA, et al., Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq. PLoS One 2015; 10: e0135817.
13. Network CGA., Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487: 330-7.
14. Brown JM, Attardi LD., The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 2005; 5: 231-7.
15. Sottoriva A, Spiteri I, Piccirillo SG, et al., Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci USA 2013; 110: 4009-14.
16. Tan DS, Camilleri-Broet S, Tan EH, et al., Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics. Int J Cancer 2014; 135: 1092-100.
17. Gerlinger M, Rowan AJ, Horswell S, et al., Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-92.
18. Polyak K., Heterogeneity in breast cancer. J Clin Invest 2011; 121: 3786-8.
19. Brocks D, Assenov Y, Minner S, et al., Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. Cell Rep 2014; 8: 798-806.
20. Lee JY, Yoon JK, Kim B, et al., Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing. BMC Cancer 2015; 15: 85
21. Hoadley KA, Yau C, Wolf DM, et al., Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 2014; 158: 929-44.
22. Badve S, Dabbs DJ, Schnitt SJ, et al., Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol 2011; 24: 157-67.
23. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, et al., Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 2009; 69: 4116-24.
24. Weigelt B, Reis-Filho JS., Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 2009; 6: 718-30.
25. Geyer FC, Marchio C, Reis-Filho JS., The role of molecular analysis in breast cancer. Pathology 2009; 41: 77-88.
26. Weigelt B, Pusztai L, Ashworth A, et al., Challenges translating breast cancer gene signatures into the clinic. Nat Rev Clin Oncol 2012; 9: 58-64.
27. Lips EH, Mulder L, Oonk A, et al., Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers. Br J Cancer 2013; 108: 2172-7.
28. Kim KT, Lee HW, Lee HO, et al., Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells. Genome Biol 2015; 16: 127
29. Fidler IJ, Hart IR., Biological diversity in metastatic neoplasms: origins and implications. Science 1982; 217: 998-1003.
30. Ding L, Ellis MJ, Li S, et al., Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010; 464: 999-1005.
31. Mullighan CG, Phillips LA, Su X, et al., Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 2008; 322: 1377-80.
32. Tam WL, Weinberg RA., The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med 2013; 19: 1438-49.
33. Marusyk A, Almendro V, Polyak K., Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 2012; 12: 323-34.
34. Jan M, Snyder TM, Corces-Zimmerman MR, et al., Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med 2012; 4: 149ra18
35. Marusyk A, Polyak K., Tumor heterogeneity: causes and consequences. Biochim Biophys Acta Rev Cancer 2010; 1805: 105-17.
36. Medema JP., Cancer stem cells: the challenges ahead. Nat Cell Biol 2013; 15: 338-44.
37. Alix-Panabieres C, Pantel K., Challenges in circulating tumour cell research. Nat Rev Cancer 2014; 14: 623-31.
38. Maldiney T, Bessière A, Seguin J, et al., The in vivo activation of persistent nanophosphors for optical imaging of vascularization, tumours and grafted cells. Nat Mater 2014; 13: 418-26.
39. Zardavas D, Irrthum A, Swanton C, et al., Clinical management of breast cancer heterogeneity. Nat Rev Clin Oncol 2015; 12: 381-394.
40. Cummings EB., Streaming dielectrophoresis for continuous-flow microfluidic devices. IEEE Eng Med Biol Mag 2003; 22: 75-84.
41. Schulz KR, Danna EA, Krutzik PO, et al., Single-cell phospho-protein analysis by flow cytometry. Curr Protoc Immunol 2012;Chapter 8:Unit 8. 17: 1-20.
42. Bandura DR, Baranov VI, Ornatsky OI, et al., Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem 2009; 81: 6813-22.
43. Giesen C, Wang HAO, Schapiro D, et al., Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Meth 2014; 11: 417-22.
44. Rothberg JM, Sameni M, Moin K, et al., Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment. Biochim Biophys Acta 2012; 1824: 123-32.
45. Thurber GM, Yang KS, Reiner T, et al., Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo. Nat Commun 2013; 4: 1504.
46. Gossett DR, Tse HTK, Lee SA, et al., Hydrodynamic stretching of single cells for large population mechanical phenotyping. Proc Natl Acad Sci USA 2012; 109: 7630-5.
47. Jing T, Ramji R, Warkiani ME, et al., Jetting microfluidics with size-sorting capability for single-cell protease detection. Biosens Bioelectron 2014;66:19-23.
48. Du GS, Pan JZ, Zhao SP, et al., Cell-based drug combination screening with a microfluidic droplet array system. Anal Chem 2013; 85: 6740-7.
49. Weaver WM, Tseng P, Kunze A, et al., Advances in high-throughput single-cell microtechnologies. Curr Opin Biotechnol 2014; 25: 114-23.
50. Macaulay IC, Voet T., Single cell genomics: advances and future perspectives. PLoS Genet 2014; 10: e1004126.
51. Dalerba P, Kalisky T, Sahoo D, et al., Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol 2011; 29: 1120-7.
52. Ennen M, Keime C, Kobi D, et al., Single-cell gene expression signatures reveal melanoma cell heterogeneity. Oncogene 2014;34(25):3251-63.
53. Ramskold D, Luo S, Wang YC, et al., Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol 2012; 30: 777-82.
54. Wang D, Bodovitz S., Single cell analysis: the new frontier in 'omics'. Trends Biotechnol 2010; 28: 281-90.
55. Sun J, Masterman-Smith MD, Graham NA, et al., A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens. Cancer Res 2010; 70: 6128-38.
56. Sarkar A, Kolitz S, Lauffenburger DA, et al., Microfluidic probe for single-cell analysis in adherent tissue culture. Nat Commun 2014; 5: 3421
57. Agasti SS, Liong M, Peterson VM, et al., Photocleavable DNA barcode-Antibody conjugates allow sensitive and multiplexed protein analysis in single cells. J Am Chem Soc 2012; 134: 18499-502.
58. Ullal AV, Peterson V, Agasti SS, et al., Dejan Juric2 CMC, 2 and Ralph Weissleder1,2,3,4,†. Cancer Cell Profiling by Barcoding Allows Multiplexed Protein Analysis in Fine-Needle Aspirates. Sci Transl Med 2014; 6: 219ra9.
59. Amir E-AD, Davis KL, Tadmor MD, et al., viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotech 2013; 31: 545-52.
60. Ide Y, Waki M, Ishizaki I, et al., Single cell lipidomics of SKBR-3 breast cancer cells by using time-of-flight secondary-ion mass spectrometry. Surf Interface Anal 2014; 46 (S1): 181-184.
61. Denbigh JL, Lockyer NP., ToF-SIMS as tool for profiling lipids in cancer and other diseases. Mater Sci Technol 2014;31(2):137-147.
62. Northen TR, Yanes O, Northen MT, et al., Clathrate nanostructures for mass spectrometry. Nature 2007; 449: 1033-6.
63. O'Brien PJ, Lee M, Spilker ME, et al., Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imaging. Cancer Metab 2013; 1: 4.
64. Wang Y, Waters J, Leung ML, et al., Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 2014; 512: 155-60.
65. Heitzer E, Auer M, Gasch C, et al., Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res 2013; 73: 2965-75.
66. Gasch C, Bauernhofer T, Pichler M, et al., Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin Chem 2013; 59: 252-60.
67. Easwaran H, Tsai H-C, Baylin SB., Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell 2014; 54: 716-27.
68. Lorthongpanich C, Cheow LF, Balu S, et al., Single-cell DNA-methylation analysis reveals epigenetic chimerism in preimplantation embryos. Science 2013; 341: 1110-2.
69. Chen CL, Mahalingam D, Osmulski P, et al., Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. Prostate 2013; 73: 813-26.
70. Miyamoto DT, Zheng Y, Wittner BS, et al., RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science 2015; 349: 1351-6.
71. Patel AP, Tirosh I, Trombetta JJ, et al., Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 2014; 344: 1396-401.
72. Lee MC, Lopez-Diaz FJ, Khan SY, et al., Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing. Proc Natl Acad Sci USA 2014; 111: E4726-35.
73. Baldus SE, Schaefer K-L, Engers R, et al., Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin Cancer Res 2010; 16: 790
74. Kosmidou V, Oikonomou E, Vlassi M, et al., Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications. Hum Mutat 2014; 35: 329-40.
75. Diaz LA, Jr., Williams RT, Wu J, et al., The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 2012; 486: 537-40.
76. Gajewski TF, Schreiber H, Fu Y-X., Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 2013; 14: 1014-22.
77. Satija R, Shalek AK., Heterogeneity in immune responses: from populations to single cells. Trends Immunol 2014; 35: 219-29.
78. Bendall SC, Simonds EF, Qiu P, et al., Nolan Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011; 332: 687-96.
79. Shi Q, Qin L, Wei W, et al., Single-cell proteomic chip for profiling intracellular signaling pathways in single tumor cells. Proc Natl Acad Sci USA 2011;109(2):419-424.
80. Ouyang M, Huang H, Shaner NC, et al., Simultaneous visualization of protumorigenic Src and MT1-MMP activities with fluorescence resonance energy transfer. Cancer Res 2010; 70: 2204-12.
81. Shigaki H, Baba Y, Watanabe M, et al., LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis. Gastric Cancer 2013; 16: 480-7.
82. Singh AK, Arya RK, Maheshwari S, et al., Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance. Int J Cancer 2015; 136: 1991-2000.
83. Khoo BL, Warkiani ME, Tan DS, et al., Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells. PLoS One 2014; 9: e99409.
84. Zardavas D, Baselga J, Piccart M., Emerging targeted agents in metastatic breast cancer. Nat Rev Clin Oncol 2013; 10: 191-210.
85. Yu M, Bardia A, Wittner BS, et al., Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013; 339: 580-4.
86. Alix-Panabieres C, Pantel K., Technologies for detection of circulating tumor cells: facts and vision. Lab Chip 2014; 14: 57-62.
87. Schiro PG, Zhao M, Kuo JS, et al., Sensitive and high-throughput isolation of rare cells from peripheral blood with ensemble-decision aliquot ranking. Angew Chem Int Ed Engl 2012; 51: 4618-22.
88. Lohr JG, Adalsteinsson VA, Cibulskis K, et al., Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotechnol 2014; 32: 479-84.
89. Lacroix M., Persistent use of "false" cell lines. Int J Cancer 2007; 122: 1-4.
90. Marrinucci D, Bethel K, Lazar D, et al., Cytomorphology of circulating colorectal tumor cells: a small case series. J Oncol 2010; 2010:1-7.
91. Powell AA, Talasaz AH, Zhang H, et al., Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines. PLoS One 2012; 7: e33788.
92. Nemes P, Knolhoff AM, Rubakhin SS, et al., Single-cell metabolomics: changes in the metabolome of freshly isolated and cultured neurons. ACS Chem Neurosci 2012; 3:782-792.
93. Deng G, Krishnakumar S, Powell AA, et al., Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow. BMC Cancer 2014; 14: 456
94. Fernandez SV, Bingham C, Fittipaldi P, et al., TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients. Breast Cancer Res 2014; 16: 445.
95. Khoo BL, Lee SC, Kumar P, et al., Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. Oncotarget 2015;6(17):15578-93.
96. Cayrefourcq L, Mazard T, Joosse S, et al., Establishment and characterization of a cell line from human circulating colon cancer cells. Cancer Res 2015; 75: 892-901.
97. Munsky B, Neuert G, van Oudenaarden A., Using gene expression noise to understand gene regulation. Science 2012; 336: 183-7.
98. Grun D, Kester L, van Oudenaarden A., Validation of noise models for single-cell transcriptomics. Nat Methods 2014; 11: 637-40.
99. Shiroguchi K, Jia TZ, Sims PA, et al., Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodes. Proc Natl Acad Sci USA 2012; 109: 1347-52.
100. Kim JK, Kolodziejczyk AA, Illicic T, et al., Characterizing noise structure in single-cell RNA-seq distinguishes genuine from technical stochastic allelic expression. Nat Commun 2015; 6: 8687.
101. Gupta PB, Fillmore CM, Jiang G, et al., Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011; 146: 633-44.
102. Landan G, Cohen NM, Mukamel Z, et al., Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues. Nat Genet 2012; 44: 1207-14.
103. Basik M, Aguilar-Mahecha A, Rousseau C, et al., Batist Biopsies: Next-generation biospecimens for tailoring therapy. Nat Rev Clin Oncol 2013; 10: 437-50.
104. Ting DT, Wittner BS, Ligorio M, et al., Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell Rep 2014; 8: 1905-18.
105. Thiery JP., Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-54.
106. Zhang L, Ridgway LD, Wetzel MD, et al., The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med 2013; 5: 180ra48.
107. Ritchie MD, Holzinger ER, Li R, et al., Methods of integrating data to uncover genotype-phenotype interactions. Nat Rev Genet 2015; 16: 85-97.
108. Brookes AJ, Robinson PN., Human genotype-phenotype databases: aims, challenges and opportunities. Nat Rev Genet 2015; 16: 702-15.
109. International Cancer Genome C, Hudson TJ, Anderson W, et al., International network of cancer genome projects. Nature 2010; 464: 993-8.
110. Venkatesan BM, Bashir R., Nanopore sensors for nucleic acid analysis. Nat Nanotechnol 2011; 6: 615-24.
111. Jain M, Fiddes IT, Miga KH, et al., Improved data analysis for the MinION nanopore sequencer. Nat Methods 2015; 12: 351-6.
112. Riethdorf S, Fritsche H, Muller V, et al., Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007; 13: 920-8.
113. Cristofanilli M, Budd GT, Ellis MJ, et al., Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781-91.
114. Cristofanilli M, Hayes DF, Budd GT, et al., Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005; 23: 1420-30.
115. Huang B, Bates M, Zhuang X., Super resolution fluorescence microscopy. Annu Rev Biochem 2009; 78: 993-1016.
116. Mukherjee S, Speed TP., Network inference using informative priors. Proc Natl Acad Sci USA 2008; 105: 14313-8.
117. Everley PA, Krijgsveld J, Zetter BR, et al., Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol Cell Proteomic 2004; 3: 729-35.
118. Elowitz MB, Levine AJ, Siggia ED, Swain PS., Stochastic Gene Expression in a Single Cell. Science 2002; 297: 1183-6.
119. Pailler E, Julien A, Amélie B, et al., Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non-Small-Cell Lung Cancer. JCO 2013; 31: 2273-81.